Insider · CIK 0001796536

Sanders Corazon (Corsee) D.

Reports to the SEC for 5 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001796536

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-29	LEGNLegend Biotech CorpS Sale	Director	SSale	−27.4K sh	$9.46	−$259K	52,731
2026-09-24	LEGNLegend Biotech CorpA Award	Director	AAward	+21K sh	—	—	80,101
2026-08-17	CLDICalidi Biotherapeutics, Inc. · Non-Qualified Stock Options (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2026-06-15	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−2,000 sh	$25.05	−$50.1K	21,095
2026-05-22	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−212 sh	$309.59	−$65.6K	0
2026-05-14	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+7,751 sh	—	—	23,095
2026-05-14	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,058
2025-11-26	ONCBeOne Medicines Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+2,627 sh	$159.03	+$418K	2,627
2025-11-26	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−1,823 sh	$340.20	−$620K	804
2025-11-26	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−804 sh	$342.47	−$275K	0
2025-11-26	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−34.2K sh	—	—	0
2025-09-05	ONCBeOne Medicines Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+2,665 sh	$155.68	+$415K	2,665
2025-09-05	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−2,665 sh	$337.00	−$898K	0
2025-09-05	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−34.6K sh	—	—	0
2025-06-20	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−2,405 sh	$37.39	−$89.9K	15,344
2025-05-21	ONCBeOne Medicines Ltd.A Award	Director	AAward	+11K sh	—	—	57,226
2025-05-21	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+22.8K sh	—	—	22,750
2025-05-15	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,740 sh	—	—	17,749
2025-05-15	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,787
2024-09-27	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2024-07-02	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−584 sh	$40.98	−$23.9K	12,009
2024-06-18	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,345 sh	—	—	12,593
2024-06-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,900 sh	—	—	9,900
2024-06-10	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−1,737 sh	$41.10	−$71.4K	7,248
2024-06-05	ONCBeOne Medicines Ltd.A Award	Director	AAward	+16.3K sh	—	—	46,241
2024-06-05	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+34.2K sh	—	—	34,151
2023-10-27	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2023-06-30	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−585 sh	$46.76	−$27.4K	8,985
2023-06-23	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−100 sh	$180.74	−$18.1K	478
2023-06-23	ONCBeOne Medicines Ltd.S Sale	Director	SSale	−478 sh	$182.65	−$87.3K	0
2023-06-15	ONCBeOne Medicines Ltd.A Award	Director	AAward	+12.9K sh	—	—	37,414
2023-06-15	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	26,975
2023-06-08	RAREUltragenyx Pharmaceutical Inc.S Sale	Director	SSale	−1,485 sh	$51.65	−$76.7K	9,570
2023-06-07	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,860 sh	—	—	11,055
2023-06-07	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,110 sh	—	—	7,110
2022-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,300 sh	—	—	7,195
2022-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,245 sh	—	—	6,245
2022-06-22	ONCBeOne Medicines Ltd.A Award	Director	AAward	+16.7K sh	—	—	24,492
2022-06-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+34.6K sh	—	—	34,645
2022-06-03	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-29	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,895 sh	—	—	3,895
2021-06-29	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,255 sh	—	—	7,255
2021-06-16	ONCBeOne Medicines Ltd.A Award	Director	AAward	+7,800 sh	—	—	7,800
2021-06-16	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,498
2021-06-03	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-08-24	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+27.5K sh	—	—	27,482
2020-05-28	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-12-19	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Oct 14
Sanders Corazon (Corsee) D.0001796536-26-000010
SEC(opens sec.gov)
Sep 284
Sanders Corazon (Corsee) D.0001796536-26-000009
SEC(opens sec.gov)
Aug 194
Sanders Corazon (Corsee) D.0001493152-26-039285
SEC(opens sec.gov)
Jun 154
Sanders Corazon (Corsee) D.0001796536-26-000007
SEC(opens sec.gov)
May 274
Sanders Corazon (Corsee) D.0001796536-26-000005
SEC(opens sec.gov)
May 184
Sanders Corazon (Corsee) D.0001796536-26-000004
SEC(opens sec.gov)
Dec 14
Sanders Corazon (Corsee) D.0001796536-25-000005
SEC(opens sec.gov)
Sep 94
Sanders Corazon (Corsee) D.0001651308-25-000139
SEC(opens sec.gov)
Jun 234
Sanders Corazon (Corsee) D.0000950170-25-088878
SEC(opens sec.gov)
May 224
Sanders Corazon (Corsee) D.0001651308-25-000086
SEC(opens sec.gov)
May 194
Sanders Corazon (Corsee) D.0000950170-25-074666
SEC(opens sec.gov)
Sep 304
Sanders Corazon (Corsee) D.0000950170-24-110454
SEC(opens sec.gov)

Companies

Address

C/O LEGEND BIOTECH CORP 77 CORPORATE DRIVE, 4TH FLOOR

BRIDGEWATER, NJ, 08807